A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease (NCT07705373)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research study is to examine the effects of a 3-month personalized community-based walking program using a digital music-based device designed for self-directed gait training in people with Parkinson disease (PD). The study uses music cues delivered through this digital device to improve walking outcomes. The investigators want to know if personalized music cueing through the digital device can improve walking quality, walking ability, daily walking amount and intensity, and quality of life, while helping walking feel more automatic and require less mental effort. Participants will take part in this research study for approximately 18 weeks in total. During this time, participants will complete 4 study visits at designated research centers at Boston University, Washington University in St. Louis, or the University of Utah, depending on the site of enrollment.
Who can join: Review the eligibility criteria below.
Location: Boston University Center for Neurorehabilitation — Boston, Massachusetts
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Boston University Center for Neurorehabilitation — Boston, Massachusetts
- Washington University School of Medicine — St Louis, Missouri
- University of Utah — Salt Lake City, Utah
📞 Contact the Study Coordinator
Phone: (617) 358-6157
Email: egclarke@bu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson's Disease (PD)
- A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease — Aliso Viejo, California
- IMPACT 360 for Parkinson's Disease — Vancouver, British Columbia
- Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease — Birmingham, Alabama
- AAV2-hAADC for Parkinson's Disease (PDCS-01) — Columbus, Ohio
- Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease — Stanford, California
- A Study of Buntanetap in Participants With PD — Birmingham, Alabama
Explore by condition: All Parkinson's Disease (PD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.